Real-time enrollment status for this lung fibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06806592 |
| Recruiting Status | Recruiting |
| Condition | Lung Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06806592 is currently recruiting participants. This clinical trial study for lung fibrosis is actively seeking new participants at 33 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06806592 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06806592 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.